Skip to main content
SpringerLink
Log in

Principles of Medical Oncology

  • Chapter
Concise Manual of Hematology and Oncology

  • 2189 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Cancer Society. Cancer Facts and Figures 2003. Atlanta, GA, 2003

    Google Scholar 

  2. Jemal A, Siegel R., Ward E et al. Cancer Statistics, 2007. CA Cancer J Clin 2007;57:43–66

    PubMed  Google Scholar 

  3. Lichtenstein P, Holm NV, Verkasalo PK et al. Environmental and heritable factors in the causation of cancer. N Engl J Med 2000;343:78–85

    Article  PubMed  CAS  Google Scholar 

  4. Kamangar F, Dores GM, Anderson WF. Patterns of Cancer incidence, mortality, and prevalence across five continents. J Clin Oncol 2006;24:2137–50.

    Article  PubMed  Google Scholar 

  5. http://www.cancer.org/ American Cancer Society

    Google Scholar 

  6. http://www.iacr.com.fr/ Intl. Association of Cancer Registries

    Google Scholar 

  7. http://seer.cancer.gov/ NCI SEER Database

    Google Scholar 

  8. Bergen AW, Caporaso N. Cigarette smoking. J Natl Cancer Inst 1999;91:1365–75

    Article  PubMed  CAS  Google Scholar 

  9. Berrington de Gonzales A, Darby S. Risk of cancer from diagnostic X-rays. Lancet 2004;363:345–51

    Article  Google Scholar 

  10. Hahn WC, Weinberg RA. Rules for making tumor cells. N Eng J Med 2002;347:1593–603

    Article  CAS  Google Scholar 

  11. Jordan CT, Guzman ML, Noble M. Cancer stem cell. N Engl J Med 2006;355:1253–61

    Article  PubMed  CAS  Google Scholar 

  12. Lichtenstein P, Holm NV, Verkasalo PK et al. Environmental and heritable factors in the causation of cancer. N Eng J Med 2000;343:78–85

    Article  CAS  Google Scholar 

  13. Ponder BAJ. Cancer genetics. Nature 2001;411:336–41

    Article  PubMed  CAS  Google Scholar 

  14. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-99

    Article  PubMed  CAS  Google Scholar 

  15. World Health Organisation IARC monographs on the evaluation of carcinogenic risks to humans, 1–74. Lyon, IARC, 1972-2000

    Google Scholar 

  16. http://www.iarc.fr Intl. Agency for Research on Cancer

    Google Scholar 

  17. http://www.nlm.nih.gov/pubs/factsheets/ccrisfs.html Chemical Carcinogen Information

    Google Scholar 

  18. http://ehp.niehs.nih.gov/roc/toc10.html NIH Report on Carcinogens

    Google Scholar 

  19. http://potency.berkeley.edu/cpdb.html Carcinogenic Potency Database

    Google Scholar 

  20. http://cancer.gov/cancerinfo/prevention-genetics-causes Cancer Genetics, NIH

    Google Scholar 

  21. http://AtlasGeneticsOncology.org Cytogenetics Atlas

    Google Scholar 

  22. http://www.carcinogenesis.com/home/ Journal of Carcinogenesis

    Google Scholar 

  23. http://www.nature.com/nrc/poster/subpathways/index.html A subway map to cancer

    Google Scholar 

  24. Akashi K, Traver D, Kondo M et al. Lymphoid development from hematopoietic stem cells. Int J Hematol 1999;69:217–26

    PubMed  CAS  Google Scholar 

  25. Baraldi-Junkins CA, Beck AC, Rothstein G. Hematopoiesis and cytokines. Hematol Oncol Clin North Am 2000;14:45–61

    Article  PubMed  CAS  Google Scholar 

  26. Broxmeyer HE, Kim CH. Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities. Exp Hematol 1999;27:1113–23

    Article  PubMed  CAS  Google Scholar 

  27. Fey MF. Normal and malignant hematopoiesis. Ann Oncol 2007;18(suppl. 1):i9–i13

    Article  PubMed  Google Scholar 

  28. Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood 2002;100:1532–42

    Article  PubMed  CAS  Google Scholar 

  29. Hoang T. The origin of hematopoietic cell type diversity. Oncogene 2004;23:7188–98

    Article  PubMed  CAS  Google Scholar 

  30. Kondo M, Wagers AJ, Manz MG et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 2003;21:759–806

    Article  PubMed  CAS  Google Scholar 

  31. Kyba M, Daley GQ. Hematopoiesis from embryonic stem cells: lessons from and for ontogeny. Exp Hematol 2003;31:994–1006

    PubMed  CAS  Google Scholar 

  32. LeBien TW. Fates of human B-cell precursors. Blood 2000;96:9–23

    PubMed  CAS  Google Scholar 

  33. http://www.hematology.org American Society of Hematology (ASH)

    Google Scholar 

  34. http://www.bloodline.net/ Hematological Education and News

    Google Scholar 

  35. http://pathy.med.nagoya-u.ac.jp/atlas/doc/ Hematology Atlas of the University of Nagoya

    Google Scholar 

  36. http://www.hematologyatlas.com/ Hematology Atlas

    Google Scholar 

  37. Boyle P, Autier P, Bartelink H et al. European Code Against Cancer and scientific justification: third version (2003). Ann Oncol 2003;14:973–1005

    Article  PubMed  CAS  Google Scholar 

  38. Chlebowski RT, Col N et al. ASCO Technology Assessment of Pharmacology Interventions for Breast Cancer Risk Reduction Including Tamoxifen, Raloxifen and Aromatase Inhibition. J Clin Oncol 2002;20:3328–43

    Article  PubMed  CAS  Google Scholar 

  39. Imperiale TF. Aspirin and the prevention of colorectal cancer. N Engl J Med 2003;348:879–80

    Article  PubMed  Google Scholar 

  40. Jordan VC. Chemoprevention of breast cancer with selective oestrogenreceptor modulators. Nat Rev Cancer 2007,7:46–53

    Article  PubMed  CAS  Google Scholar 

  41. Key TJ, Allen NE et al. The effect of diet on risk of cancer. Lancet 2002;360:861–68

    Article  PubMed  CAS  Google Scholar 

  42. Koutsky LA, Ault KA et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645–51

    Article  PubMed  CAS  Google Scholar 

  43. Kushi LH, Byers T, Doyle C et al. ACS Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity. CA Cancer J Clin 2006;56:254–81

    PubMed  Google Scholar 

  44. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the US, 2007: A review of current guidelines, practies, and prospects. CA Cancer J Clin 2007;57:90–104

    PubMed  CAS  Google Scholar 

  45. http://www.cancerprevention.org/ Cancer Prevention Foundation

    Google Scholar 

  46. http://www.cancerprev.org/ Cancer Detection and Prevention

    Google Scholar 

  47. http://www.cancerpreventionfund.com/ National Cancer Prevention Fund

    Google Scholar 

  48. http://www.preventcancer.com/ Cancer Prevention Coalition

    Google Scholar 

  49. http://www.prevention.cancer.gov Division of Cancer Prevention (NCI)

    Google Scholar 

  50. http://www.cdc.gov/cancer/az/ Center for Disease Control (CDC)

    Google Scholar 

  51. WHO. International Classification of Diseases, 10th edn (ICD-10). WHO, Genf, 1996

    Google Scholar 

  52. WHO. ICD-0 International Classification of Diseases for Oncology, 3rd edn. WHO, Genf, 2000

    Google Scholar 

  53. http://www.who.int/whosis/icd10/ World Health Organization (WHO)

    Google Scholar 

  54. http://www.cdc.gov/nchs National Center for Health Statistics (NCHS)

    Google Scholar 

  55. Center for Disease Control (CDC)

    Google Scholar 

  56. Greene FL, Page DL, Fleming ID et al. (eds) AJCC Cancer Staging Handbook. TNM Classification of Malignant Tumors, 6th edn. Springer, New York, 2002

    Google Scholar 

  57. Gospodarowicz MK, Miller D, Groome PA et al. The process for continuous improvement of the TNM classification. Cancer 2004;100:1–5

    Article  PubMed  Google Scholar 

  58. Sobin LH, Wittekind C (eds). TNM Classification of Malignant Tumors, 6th edn. Wiley, New York, 2002

    Google Scholar 

  59. WHO. International Classification of Diseases, 10th edn (ICD-10). WHO, Genf, 1996

    Google Scholar 

  60. http://www.cancerstaging.org American Joint Committee on Cancer (AJCC)

    Google Scholar 

  61. http://www.cancer.gov National Cancer Institute (NCI), with Cancernet

    Google Scholar 

  62. http://www.uicc.org Union Internationale Contre le Cancer (UICC)

    Google Scholar 

  63. Julia H, Rowland JH, Hewitt M, Ganz PA. Cancer survivorship: a new challenge in delivering quality cancer care. J Clin Onc 2006;24:5101–4

    Article  Google Scholar 

  64. http://www.cancer.org ACS, Clinical Practice Guidelines

    Google Scholar 

  65. http://www.guideline.gov National Guideline Clearinghouse (NGC)

    Google Scholar 

  66. http://cancer.gov/cancerinformation National Cancer Institute (NCI), with Cancernet

    Google Scholar 

  67. http://www.cebm.net Center for Evidence-Based Medicine

    Google Scholar 

  68. Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996;32A:1135–41

    Article  PubMed  CAS  Google Scholar 

  69. Garman KS, Cohen HJ. Functional status and the elderly patient. Crit Rev Oncol Hematol 2002;43:191–298

    Article  PubMed  Google Scholar 

  70. Mor V, Laliberte L, Morris JN et al. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 1984;53:2002–7

    Article  PubMed  CAS  Google Scholar 

  71. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649–55

    Article  PubMed  CAS  Google Scholar 

  72. http://www.who.int World Health Organization (WHO)

    Google Scholar 

  73. http://ecog.dfci.harvard.edu Eastern Cooperative Oncology Group (ECOG)

    Google Scholar 

  74. http://www.fda.gov/cder/cancer Food and Drug Administration (FDA) Oncology Tools

    Google Scholar 

  75. Green S, Weiss GR. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 1992;10:239–53

    Article  PubMed  CAS  Google Scholar 

  76. Jaffe CC. Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol 2006;24:3245–51

    Article  PubMed  Google Scholar 

  77. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205–16

    Article  PubMed  CAS  Google Scholar 

  78. WHO. WHO handbook for reporting results of cancer treatment. WHO, 1979

    Google Scholar 

  79. http://www.who.int World Health Organization (WHO)

    Google Scholar 

  80. http://www3.cancer.gov/dip/RECIST.htm NCI, RECIST Criteria

    Google Scholar 

  81. http://www.swog.org Southwest Oncology Group (SWOG)

    Google Scholar 

  82. Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf 1999;20:109–17

    Article  PubMed  CAS  Google Scholar 

  83. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, management. Lancet 2000;356:1255–9

    Article  PubMed  CAS  Google Scholar 

  84. Hesslewood SR. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1999. Eur J Nucl Med 2001;28:2–8

    Google Scholar 

  85. Pirmohamed M, Breckenridge AM, Kitteringham NR et al. Adverse drug reactions. BMJ 1998;316:1295–8

    PubMed  CAS  Google Scholar 

  86. Trotti A, Colevas AD, Setser A et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176–81

    Article  PubMed  Google Scholar 

  87. Vincent C. Understanding and responding to adverse events. N Engl J Med 2003;348:1051–6

    Article  PubMed  Google Scholar 

  88. http://ctep.cancer.gov/reporting/ctc.html NCI Common Toxicity Criteria

    Google Scholar 

  89. http://ecog.dfci.harvard.edu/~ecogdba/general/common_tox.html ECOG Common Toxicity Criteria

    Google Scholar 

  90. http://www.accessdata.fda.gov/scripts/cder/onctools/toxicity.cfm FDA, Common Toxicity Criteria

    Google Scholar 

  91. de Haes J, Curran D, Young T et al. Quality of life evaluation in oncological clinical trials – the EORTC model. Eur J Cancer 2000;36:821–5

    Article  PubMed  Google Scholar 

  92. Giesler RB, Williams SD. Opportunities and challenges: assessing quality of life in clinical trials. J Natl Cancer Inst 1998;90:1498–9

    Article  PubMed  CAS  Google Scholar 

  93. Holzner B, Bode RK, Hahn EA et al. Equating EORTC QLQ–C30 and FACT–G scores and its use in oncological research. Eur J Cancer 2006;42:3169–77

    Article  PubMed  CAS  Google Scholar 

  94. http://www.fda.gov Food and Drug Administration (FDA)

    Google Scholar 

  95. http://www.nci.nih.gov National Cancer Institute (NCI)

    Google Scholar 

  96. http://www.eortc.be/home/qol/ European Organization for Research and Treatment of Cancer (EORTC), “Quality of Life Web Site”

    Google Scholar 

  97. http://www.isoqol.org/ International Society for Quality of Life Research

    Google Scholar 

  98. Ayanian JZ, Crischilles EA, Wallace RB et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 2004;22:2992–6

    Article  PubMed  Google Scholar 

  99. Ray-Coquard I, Philip T, de Laroche G et al. A controlled before-after study: impact of a clinical guidelines program and regional cancer network organization on medical practice. Br J Cancer 2002;86:313–21

    Article  PubMed  CAS  Google Scholar 

  100. Schneider EC, Epstein AM, Malin JL et al. Developing a system to assess the quality of cancer care: ASCO’s National Initiative on Cancer Care Quality. J Clin Oncol 2004;22:2985–91

    Article  PubMed  Google Scholar 

  101. Vardy J, Tannock IF. Quality of cancer care. Ann Oncol 2004;15:1001–6

    Article  PubMed  CAS  Google Scholar 

  102. http://www.cebm.net Evidence-Based Medicine, Oxford

    Google Scholar 

  103. http://www.guideline.gov National Guideline Clearinghouse (NGC)

    Google Scholar 

  104. http://cochrane.org/docs/ebm.htm Cochrane Library, Reviews for EBM

    Google Scholar 

  105. Casali P, Licitra L, Tondini C et al. START: a European state-of-the-art on-line instrument for clinical oncologists. Ann Oncol 1999;10:769–73

    Article  PubMed  CAS  Google Scholar 

  106. Eysenbach G. The impact of the internet on treatment outcomes. CA Cancer J Clin 2003;53:355–71

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Oncology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Dietmar P. Berger, Hartmut Henß, Uwe Martens & Monika Engelhardt

  2. Department of Hematology and Oncology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Hartmut Bertz

  3. Klinik für Hämatologie/Onkologie, Städt. Krankenhaus Süd, Sana Kliniken Lübeck, Kronsforder Allee 71/73, 23560, Lübeck, Germany

    Sebastian Fetscher

Authors
  1. Dietmar P. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hartmut Henß
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Uwe Martens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hartmut Bertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Monika Engelhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sebastian Fetscher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Hematology and Oncology, University Medical Center, Hugstetter Str. 55, 79106, Freiburg, Germany

    Dietmar P. Berger , Monika Engelhardt  & Roland Mertelsmann ,  & 

  2. Tumorzentrum Ludwig-Heilmeyer, Comprehensive Cancer Center, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Hartmut Henß

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Berger, D., Henß, H., Martens, U., Bertz, H., Engelhardt, M., Fetscher, S. (2008). Principles of Medical Oncology. In: Berger, D., Engelhardt, M., Henß, H., Mertelsmann, R. (eds) Concise Manual of Hematology and Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73277-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-73277-8_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-73276-1

  • Online ISBN: 978-3-540-73277-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation